Severe neonatal hemolysis due to a maternal antibody to the low-frequency Rh antigen Cw

American Journal of Perinatology

Volumn 23, Issue 4, 2006, Pages 213-217

  May Wewers, Julie ^a,b   Kaiser, Jeffrey R ^a   Moore, Ellen Kay ^b   Blackall, Douglas P ^a,b  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^b ARKANSAS CHILDREN S HOSPITAL   (United States)

Author keywords

Hemolysis; Hemolytic disease of the newborn; Red blood cells

Indexed keywords

MATERNAL ANTIBODY; RHESUS ANTIGEN; RHESUS ANTIGEN C W; UNCLASSIFIED DRUG;

ALLOIMMUNIZATION; ANEMIA; BLOOD GROUP RHESUS SYSTEM; CASE REPORT; CAUCASIAN; ERYTHROCYTE; FEMALE; HUMAN; HYPERBILIRUBINEMIA; NEWBORN; NEWBORN HEMOLYTIC DISEASE; PREGNANCY; PRIORITY JOURNAL; REVIEW;

ADULT; ANTIBODY SPECIFICITY; ERYTHROBLASTOSIS, FETAL; FEMALE; HUMANS; HYPERBILIRUBINEMIA, NEONATAL; INFANT, NEWBORN; ISOANTIGENS; PREGNANCY; PREGNANCY COMPLICATIONS, HEMATOLOGIC; RH-HR BLOOD-GROUP SYSTEM; SEVERITY OF ILLNESS INDEX;

EID: 33646489286     PISSN: 07351631     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2006-934098     Document Type: Review

References (20)

1. Reid ME, Lomas-Francis C. The Blood Group Antigen Factsbook. San Diego: Academic Press; 1997:111-112
2. w causing haemolytic disease of the newborn. Lancet 1947;2:545-546
3. w). Pediatrics 1958;21:443-444
4. w sensitization resulting in hemolytic disease of the newborn. Can Med Assoc J 1963;89:28
5. w). J Pediatr 1959;54:484-487
6. w. Acta Paediatr Scand 1982;71:703-704
7. w. Am J Med Technol 1967;33:175-178
8. w. Aust N Z J Obstet Gynaecol 1982;22:161-162
9. w alloimmunization. Vox Sang 1993;64:226-230
10. Marsh WL. Scoring of hemagglutination reactions. Transfusion 1972;12:352-353
11. Brecher ME, ed. AABB Technical Manual. 14th ed. Bethesda, MD: American Association of Blood Banks; 2002
12. Garratty G. Screening for RBC antibodies: what should we expect from antibody detection RBCs. Immunohematol 2002;18:71-77
13. Judd WJ, Luban NLC, Ness PM, et al. Prenatal and perinatal immunohematology: recommendations for serologic management of the fetus, newborn infant, and obstetric patient. Transfusion 1990;30:175-183
14. Hadley AG. In vitro assays to predict the severity of hemolytic disease of the newborn. Transfus Med Rev 1995;9:302-313
15. Luban NL. Hemolytic disease of the newborn: progenitor cells and late effects. N Engl J Med 1998;338:830-831
16. Vaughan JI, Warwick R, Letsky E, et al. Erythropoietic suppression in fetal anemia because of Kell alloimmunization. Am J Obstet Gynecol 1994;171:247-252
17. Weiner CP, Widness JA. Decreased fetal erythropoiesis and hemolysis in Kell hemolytic anemia. Am J Obstet Gynecol 1996;174:547-551
18. Vaughan JI, Manning M, Warwick RM, et al. Inhibition of erythroid progenitor cells by anti-Kell antibodies in fetal alloimmune anemia. N Engl J Med 1998;338:798-803
19. Bony V, Gane P, Bailly P, Cartron JP. Time-course expression of polypeptides carrying blood group antigens during human erythroid differentiation. Br J Haematol 1999;107:263-274
20. Judd WJ. Practice guidelines for prenatal and perinatal immunohematology, revisited. Transfusion 2001;41:1445-1452